Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1973 1
1988 4
1994 1
1995 1
1996 1
1997 2
1998 7
1999 3
2000 1
2001 1
2002 2
2003 1
2005 3
2006 2
2007 11
2008 3
2009 1
2010 3
2011 2
2012 4
2013 3
2014 6
2015 7
2016 8
2018 4
2019 1
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R. Xing L, et al. Among authors: clynes r. Nat Med. 2014 Sep;20(9):1043-9. doi: 10.1038/nm.3645. Epub 2014 Aug 17. Nat Med. 2014. PMID: 25129481 Free PMC article.
Redirected T Cell Cytotoxicity in Cancer Therapy.
Clynes RA, Desjarlais JR. Clynes RA, et al. Annu Rev Med. 2019 Jan 27;70:437-450. doi: 10.1146/annurev-med-062617-035821. Epub 2018 Oct 31. Annu Rev Med. 2019. PMID: 30379598 Review.
Protective mechanisms of IVIG.
Clynes R. Clynes R. Curr Opin Immunol. 2007 Dec;19(6):646-51. doi: 10.1016/j.coi.2007.09.004. Epub 2007 Nov 26. Curr Opin Immunol. 2007. PMID: 18032008 Review. No abstract available.
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Ravandi F, Bashey A, Foran J, Stock W, Mawad R, Short N, Yilmaz M, Kantarjian H, Odenike O, Patel A, Garcha R, Ainsworth WB, Clynes R, Kanodia J, Ding Y, Li H, Kye S, Mims A. Ravandi F, et al. Among authors: clynes r. Blood Adv. 2023 Nov 14;7(21):6492-6505. doi: 10.1182/bloodadvances.2023010956. Blood Adv. 2023. PMID: 37647601 Free PMC article. Clinical Trial.
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang E, Whiteside TL, Zhao Y, Zwierzina H, Butterfield LH, Fox BA. Yuan J, et al. Among authors: clynes r. J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016. J Immunother Cancer. 2016. PMID: 26788324 Free PMC article. Review.
Genetic basis of alopecia areata: a roadmap for translational research.
Jabbari A, Petukhova L, Cabral RM, Clynes R, Christiano AM. Jabbari A, et al. Among authors: clynes r. Dermatol Clin. 2013 Jan;31(1):109-17. doi: 10.1016/j.det.2012.08.014. Epub 2012 Oct 23. Dermatol Clin. 2013. PMID: 23159180 Free PMC article. Review.
83 results